Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
Author(s) -
Paolo Parini,
Ulf Gustafsson,
Matt A. Davis,
Lilian Larsson,
Curt Einarsson,
Martha D. Wilson,
Mats Rudling,
Hiroshi Tomoda,
Satoshi Ōmura,
Staffan Sahlin,
Bo Angelin,
Lawrence L. Rudel,
Mats Eriksson
Publication year - 2008
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.107.157172
Subject(s) - lathosterol , medicine , endocrinology , cholesterol , fluvastatin , hmg coa reductase , apolipoprotein b , hydroxymethylglutaryl coa reductase , atorvastatin , statin , ldl receptor , liver x receptor , apolipoprotein e , reverse cholesterol transport , reductase , abcg1 , chemistry , receptor , very low density lipoprotein , abca1 , lipoprotein , sterol , simvastatin , biochemistry , enzyme , nuclear receptor , disease , transporter , campesterol , gene , transcription factor
The purpose of this study was to identify how different degrees of cholesterol synthesis inhibition affect human hepatic cholesterol metabolism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom